Navigation Links
AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds
Date:8/14/2008

SINGAPORE, Aug. 15 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced an innovative new partnership with the National Cancer Centre Singapore (NCCS) and the National University Hospital (NUH) to develop anti-cancer compounds. The collaboration, which is spelt out in a Memorandum of Understanding (MOU) that was signed today, aims to further build AstraZeneca's drug development capabilities in Asia and ultimately speed up access to new medicines of potential benefit to patients with inoperable Hepatocellular Carcinoma (HCC). HCC is a cancer that is particularly prevalent in Asia and accounts for approximately one million deaths annually worldwide.(1) Studies have also shown that more than 90 per cent of those afflicted with the cancer die within five years due to its inoperability.(1)

Dr. Brent Vose, Vice President of AstraZeneca's Oncology Therapeutic Area said: "AstraZeneca is committed to the research and development of new, targeted anti-cancer therapies in Asia to improve the lives of cancer patients, beginning with those affected by HCC. There is a huge unmet need for treatment of liver cancer in Asia, and particularly East Asia, where there are three-quarters of the world's HCC patients.(2) We have a number of promising candidates in development and look forward to seeing the results of some key studies throughout the next year."

Under the MOU, AstraZeneca and the Singapore institutions will be entering into a collaborative agreement that spans both clinical and pre-clinical development activities. The partnership also includes a Training Programme placement with the Manchester Cancer Research Centre, with whom AstraZeneca has a formal research alliance. Supported in part by the Singapore Economic Developm
'/>"/>

SOURCE AstraZeneca
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six
2. Phase III Study of Abbotts Investigational TriLipix(TM) in Combination With AstraZenecas CRESTOR(R) Meets Primary Endpoints on Key Lipids
3. AstraZeneca Submits sNDA for NEXIUM(R) I.V. for Peptic Ulcer Bleed Indication
4. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
5. AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines
6. Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
7. AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication
8. AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression
9. AstraZeneca Completes Enrollment in First Phase III Study of the Investigational Drug Vandetanib (ZACTIMA)(R) in Non-Small Cell Lung Cancer
10. New Analysis of METEOR Study Demonstrate Effects of AstraZenecas CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease
11. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)... DETROIT, Nov. 6 Caraco ... ) has launched ketorolac tromethamine ophthalmic ... US Food and Drug Administration (FDA) for Sun Pha...generic Acular® ophthalmic solution on the fi... of ketorolac is therapeutically equivalent to Acu...
(Date:11/6/2009)... SAN DIEGO, Nov. 6 NuVas...ny focused on developing products for minimally di...ced today the appointment of Michael J. Lambert as...cer, effective November 9, 2009. The Company also... updates. ,, "Michael will be an excellent comp...
(Date:11/6/2009)... SAN DIEGO, Nov. 6 Ardea...gy company focused on the development of small-mol...er and human immunodeficiency virus (HIV), today r...ts for the third quarter and nine months ended Sep...m.com/cgi-bin/prnh/20091104/ARDEALOGO ) ,, "Sin...
Breaking Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 3NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 4NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8Astellas Awards Educational Scholarships to Six Transplant Recipients Who Embody the Spirit of Giving Back 14204 1Astellas Awards Educational Scholarships to Six Transplant Recipients Who Embody the Spirit of Giving Back 14204 2Astellas Awards Educational Scholarships to Six Transplant Recipients Who Embody the Spirit of Giving Back 14204 3Astellas Awards Educational Scholarships to Six Transplant Recipients Who Embody the Spirit of Giving Back 14204 4Rural roads dangerous for young drivers 57955 1Rural roads dangerous for young drivers 57955 2NKTR 102 Shows Encouraging Anti Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplin 5029 1NKTR 102 Shows Encouraging Anti Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplin 5029 2NKTR 102 Shows Encouraging Anti Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplin 5029 3NKTR 102 Shows Encouraging Anti Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplin 5029 4NKTR 102 Shows Encouraging Anti Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplin 5029 5
...f 2008 --,-- Presentation at the Seventh Annual JM...celed; webcast of corporate update scheduled durin...22nd at 9:30 a.m. PT --, SAN DIEGO, May 20 Ardea...d that data was presented on the Company,s,lead mi...9, demonstrating,potent activity in mouse models o...
... presented today at the 39th Annual Digestive Dise...ts at increased risk for colorectal,cancer who com...detection,of cancerous lesions occurred an average...uring the three- or five-year study-required colon...group occurred 18.4 months,earlier., Data present...
Other Medicine Technology:Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis 2Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis 3Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis 4Annual FIT Testing Detects Colorectal Cancer Two Years Earlier Than Colonoscopy Alone, Study of High-Risk Population Finds 2Annual FIT Testing Detects Colorectal Cancer Two Years Earlier Than Colonoscopy Alone, Study of High-Risk Population Finds 3Annual FIT Testing Detects Colorectal Cancer Two Years Earlier Than Colonoscopy Alone, Study of High-Risk Population Finds 4Annual FIT Testing Detects Colorectal Cancer Two Years Earlier Than Colonoscopy Alone, Study of High-Risk Population Finds 5
(Date:11/8/2009)... A jury of 8 people in the Western District ...0,000 in pain and suffering for a medical malpract... and Alicia Nocera of Thomas E. Crenney and Associ...iff, Vita Monestersky and against the Uniontown Ho...abdominal hysterectomy at age 18. , ...
(Date:11/8/2009)...gest network of Hispanic health advocates committe...09 ,, WASHINGTON, Nov. 7 /PRNewswire-USNewswir...howed they have heard the voice of America,s famil...ica Act. Now the Senate must deliver, without dela...," said Dr. Jane L. Delgado, President and CEO of ...
(Date:11/8/2009)...ift Passage of H.R. 3961 to Secure the Stability o...wswire/ -- Statement Attributable to: J. James Roh.... ,, (Logo: http://www.newscom.com/cgi-bin/pr...assage of the House health reform bill, which will...hysicians and calls for swift passage of H.R. 3961...
(Date:11/8/2009)...Vote Shows Who Sides With Working Families vs. Ins...RNewswire-USNewswire/ -- On the heels of an histor... for a good, balanced health care reform bill, the...our state,s U.S. representatives voted on HR 3962,..., The legislation, which passed Saturday evening b...
(Date:11/7/2009)...ov. 7 Karen Ignagni, Pr...s (AHIP), released the following statement today o...strongly support comprehensive health care reform,...posing a complete overhaul of how health insurance...nteed coverage, elimination of pre-existing condit...
Breaking Medicine News(10 mins):Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:AHIP Statement on House Passage of H.R. 3962 2
... The bestselling guide is now fi...hether you or your loved one suffers from this chr... Hoboken, NJ (PRWEB) July 31, 2008 -- Eve...eir loved ones, as well as drug company representa...
...ON, July 30 The U.S. House of,Representatives tod...egislation that grants the U.S. Food and Drug Admi...including the authority to crack down on,tobacco m...ideration. Senator Sherrod Brown (D-OH) voted for ...
...our Reaches Half Way Point of Coast-To-Coast Journ...lth Coverage, YONKERS, N.Y., July 31 The Cover A...summer-long road trip across the,country to chroni...eports Health aims to put a face on the challenges...
...ON, July 30 The U.S. House of,Representatives tod...egislation that grants the U.S. Food and Drug Admi...including the authority to crack down on,tobacco m...ideration. Senator Tom Harkin (D-IA) is a cosponso...
... July 30 J.D. Power and Associates,announced that...ber,Satisfaction among Commercial Health Plans in ...ational Health Insurance Plan Study(SM)., This is...th Carolina and South Carolina on coverage and ben...
...tic link isn,t there for fathers, researchers say ... People whose mothers have had Alzheimer,s disease... a new study finds. , The link may be a dysfunctio...all, these findings show that their brains are not...
Other Medicine News:Health News:Diabetes For Dummies, 3rd Edition, Reports on the Latest Developments in the Field 2Health News:Diabetes For Dummies, 3rd Edition, Reports on the Latest Developments in the Field 3Health News:Diabetes For Dummies, 3rd Edition, Reports on the Latest Developments in the Field 4Health News:House Passes Historic Bill to Protect Kids From Tobacco; Senator Voinovich Should Cosponsor Legislation 2Health News:Consumer Reports Health's 'Cover America Tour' Chronicles Americans' Anxiety Over Health Care 2Health News:Consumer Reports Health's 'Cover America Tour' Chronicles Americans' Anxiety Over Health Care 3Health News:Consumer Reports Health's 'Cover America Tour' Chronicles Americans' Anxiety Over Health Care 4Health News:House Passes Historic Bill to Protect Kids from Tobacco; Senator Grassley Should Cosponsor Legislation 2Health News:J.D. Power and Associates Study Ranks Kaiser Permanente Highest in Member Satisfaction in South Atlantic Region 2Health News:Moms With Alzheimer's May Pass on Risk to Kids 2Health News:Moms With Alzheimer's May Pass on Risk to Kids 3
Ultrafoam Collagen Sponge
...iological form and function of the natural spinal ...the implant design integrates the biomechanical an...odular design concept: Three implant components ut...rome alloy endplate elements, and an ultra-high mo...
...llow for three-dimensional correction of a variety...cellent fatigue resistance to provide solid stabil...es a new dimension in flexibility in reducing the ...rability and ease of use when applying, connecting...
Spinal Imaging Platform
Medicine Products: